Ondansetron in a patient with porphyria.
De Wet
M
M
Jooste
R
R
Coccia-Portugal
M A
MA
Falkson
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D011164:Porphyrias / Q000139:chemically induced / Q000150:complications*
D000970:Antineoplastic Agents; D017294:Ondansetron